Navigation Links
Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board
Date:6/18/2013

Pensacola, FL (PRWEB) June 18, 2013

ActiGraph, a leading provider of objective physical activity and sleep/wake monitoring solutions for the global research community, announced today that Dr. Victor KR Matsudo has joined its Scientific Advisory Board. Dr. Matsudo is the Scientific Director of the Physical Fitness Research Center of São Caetano do Sul (CELAFISCS), a Professor of Medicine at Gama Filho University and the Chairman of the Agita São Paulo Program, organized by the State Secretariat of Health of São Paulo State, Brazil.

“With his distinguished medical background and notable achievements in global health promotion, Dr. Matsudo brings a wealth of experience and valuable insight to the ActiGraph Scientific Advisory Board, and we are delighted that he has joined us,” said Jeff Arnett, CEO of ActiGraph.

Dr. Matsudo is the founder of the Agita Mundo Network, an international organization dedicated to the promotion of physical activity, and he is also a founding member and Chairman of the Physical Activity Network of the Americas (RAFA/PANA) and a founding member of the International Society of Physical Activity and Health (ISPAH). Dr. Matsudo has received numerous prestigious awards in the areas of sports science and physical activity, including the International Prize of Sports Medicine in the Barcelona Olympics in 1992, the International “Philip Noël Baker” award in Sports Medicine in 1995, and the International Prince Faisal Prize of the International Federation of Physical Education in 1996. He is the editor of the Brazilian Journal of Science and Movement and an editorial board member or former member for several international scientific journals. Dr. Matsudo has authored two books, 8 book chapters and numerous research publications in the fields of physical activity and sports science.

Established in January of 2011, the ActiGraph Scientific Advisory Board’s primary objective is to provide the company with guidance and expertise as it continues to enhance its current hardware and software offerings and explores emerging applications for objective activity monitoring products. In addition to Dr. Victor KR Matsudo, the ActiGraph Scientific Advisory Board consists of Dr. Patty Freedson, Professor and Chair of the Department of Kinesiology at the University of Massachusetts Amherst; Dr. Jorge Mota, Director of the Research Centre in Physical Activity, Health and Leisure at the University of Porto; Dr. Bonnie Spring, Professor in Preventive Medicine, Psychiatry and Behavioral Sciences at the Northwestern University Feinberg School of Medicine; and Dr. Stewart Trost, Professor in the School of Human Movement Studies Department at The University of Queensland.

About ActiGraph:
ActiGraph’s extensively validated suite of hardware and software products are widely used by prominent scientific and academic organizations in more than 72 countries in research studies and clinical trials involving physical activity, energy expenditure, and sleep/wake behavior and their relationships to a wide range of health conditions including obesity, diabetes, cancer, cardiovascular disease and sleep disorders. ActiGraph monitoring solutions have delivered objective activity and sleep data to many high profile population studies including the National Health and Nutrition Examination Survey (NHANES), the European Youth Health Study, the U.K. Millennium Cohort Study and the Harvard Women’s Health Study.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10840899.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
2. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
3. BioPower Systems Awarded $5 Million from Victorian Government
4. StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500
5. Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
6. Dalia Dergham Joins Grace Century FZ LLC International Project Team
7. SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions
8. Elissa Guerra Joins Pursuit as VP of Client Solutions
9. Graphene joins the race to redefine the ampere
10. Provia Laboratories, LLC Joins Stoneham Chamber of Commerce in Massachusetts
11. Provonix Joins the Medrio Partner Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... , ... FireflySci Inc. is a go-getter type of company that continues to ... two main factors. The first is the amazing customer service that the FireflySci ... all around the world. , 2016 was a tremendous sales year for FFS and ...
(Date:1/19/2017)... 18, 2017 Acupath Laboratories, Inc., a leading ... of an Executive Committee that will guide the company,s ... John Cucci , a 15-year veteran of the ... Business Development to Chief Sales Officer .  Prior ... in senior sales leadership roles at several leading lab ...
(Date:1/18/2017)... --  Boston Biomedical , an industry leader in the ... pathways, will feature data from two clinical studies for ... Gastrointestinal Cancers Symposium, held from January 19-21, in ... is an orally-administered investigational agent designed to inhibit cancer ... cells (CSCs) possess the property of stemness – the ...
Breaking Biology Technology:
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
Breaking Biology News(10 mins):